Clinical Trial Update: Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating insulin glulisine and insulin aspart for postprandial glycemic control after a high-glycemic meal in children with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• NovoLog (insulin aspart)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED